ReP USP - Resultado da busca

Artigo de periodico
Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone (2011)
Himelfarb, Silvia Tchernin; Silva, Fernanda Abujamra; Arazi, Simone Sorkin; Farjado, Cristina M; Garofalo, Adriana; Bertolami, Marcelo C; Bertolami, Adriana; Faludi, André Arpad; Sampaio, Marcelo Ferraz; Rezende, Adriana Augusto de; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Drug Metabolism and Drug Interactions. Unidade: FCF
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, INTERLEUCINA 1, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIMELFARB, Silvia Tchernin et al. Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone. Drug Metabolism and Drug Interactions, v. 26, n. 1, p. 37-40, 2011Tradução . . Disponível em: https://doi.org/10.1515/DMDI.2011.100. Acesso em: 01 nov. 2024.
APA
Himelfarb, S. T., Silva, F. A., Arazi, S. S., Farjado, C. M., Garofalo, A., Bertolami, M. C., et al. (2011). Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone. Drug Metabolism and Drug Interactions, 26( 1), 37-40. doi:10.1515/DMDI.2011.100
NLM
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Garofalo A, Bertolami MC, Bertolami A, Faludi AA, Sampaio MF, Rezende AA de, Hirata RDC, Hirata MH. Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 37-40.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1515/DMDI.2011.100
Vancouver
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Garofalo A, Bertolami MC, Bertolami A, Faludi AA, Sampaio MF, Rezende AA de, Hirata RDC, Hirata MH. Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 37-40.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1515/DMDI.2011.100
Trabalho de evento-resumo periodico
TLR2 transcription levels in peripherical blood cells but not TLR4, IL-6 and TNF-'alpha' associated with acute myocardial infarction (2009)
Lima Neto, Lidio Gonçalves; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati; Silbiger, Vivian Nogueira; Pastorelli, Carla Prisinzano; Sampaio, M. P.; Armaganijan, Dikran; Doi, Sonia Quatelli; Rezende, Adriana Augusto de; Sousa, E. B.; Sprovieri, S. R.; Santos, E. S.; Pereira, M. P.; Hirata, Mario Hiroyuki
Source: Clinical Chemistry. Conference titles: Annual Meeting of the American Association for Clinical Chemistry. Unidade: FCF
Subjects: INFARTO DO MIOCÁRDIO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA NETO, Lidio Gonçalves et al. TLR2 transcription levels in peripherical blood cells but not TLR4, IL-6 and TNF-'alpha' associated with acute myocardial infarction. Clinical Chemistry. Washington: American Association for Clinical Chemistry. . Acesso em: 01 nov. 2024. , 2009
APA
Lima Neto, L. G., Hirata, R. D. C., Luchessi, A. D., Silbiger, V. N., Pastorelli, C. P., Sampaio, M. P., et al. (2009). TLR2 transcription levels in peripherical blood cells but not TLR4, IL-6 and TNF-'alpha' associated with acute myocardial infarction. Clinical Chemistry. Washington: American Association for Clinical Chemistry.
NLM
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MP, Armaganijan D, Doi SQ, Rezende AA de, Sousa EB, Sprovieri SR, Santos ES, Pereira MP, Hirata MH. TLR2 transcription levels in peripherical blood cells but not TLR4, IL-6 and TNF-'alpha' associated with acute myocardial infarction. Clinical Chemistry. 2009 ; 55( 6 suppl.): A222 res. E-37.[citado 2024 nov. 01 ]
Vancouver
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MP, Armaganijan D, Doi SQ, Rezende AA de, Sousa EB, Sprovieri SR, Santos ES, Pereira MP, Hirata MH. TLR2 transcription levels in peripherical blood cells but not TLR4, IL-6 and TNF-'alpha' associated with acute myocardial infarction. Clinical Chemistry. 2009 ; 55( 6 suppl.): A222 res. E-37.[citado 2024 nov. 01 ]
Trabalho de evento-resumo periodico
IL-6 -174G>C gene polymorphism can be a marker of type 2 diabetes mellitus (2009)
Hirata, Mario Hiroyuki ; Silva, F. A.; Lima Neto, Lidio Gonçalves; Luchessi, André Ducati; Silbiger, Vivian Nogueira; Rodrigues, Alice Cristina ; Bertolami, Marcelo Chiara; Tavares, Vladimir; Rezende, Adriana Augusto de; Doi, Sonia Quatelli; Sampaio, M. P.; Armaganijan, Dikran; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry. Conference titles: Annual Meeting of the American Association for Clinical Chemistry. Unidade: FCF
Subjects: DIABETES MELLITUS, BIOMARCADORES, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. IL-6 -174G>C gene polymorphism can be a marker of type 2 diabetes mellitus. Clinical Chemistry. Washington: American Association for Clinical Chemistry. . Acesso em: 01 nov. 2024. , 2009
APA
Hirata, M. H., Silva, F. A., Lima Neto, L. G., Luchessi, A. D., Silbiger, V. N., Rodrigues, A. C., et al. (2009). IL-6 -174G>C gene polymorphism can be a marker of type 2 diabetes mellitus. Clinical Chemistry. Washington: American Association for Clinical Chemistry.
NLM
Hirata MH, Silva FA, Lima Neto LG, Luchessi AD, Silbiger VN, Rodrigues AC, Bertolami MC, Tavares V, Rezende AA de, Doi SQ, Sampaio MP, Armaganijan D, Hirata RDC. IL-6 -174G>C gene polymorphism can be a marker of type 2 diabetes mellitus. Clinical Chemistry. 2009 ; 55( 6 suppl.): A223 res. E-41.[citado 2024 nov. 01 ]
Vancouver
Hirata MH, Silva FA, Lima Neto LG, Luchessi AD, Silbiger VN, Rodrigues AC, Bertolami MC, Tavares V, Rezende AA de, Doi SQ, Sampaio MP, Armaganijan D, Hirata RDC. IL-6 -174G>C gene polymorphism can be a marker of type 2 diabetes mellitus. Clinical Chemistry. 2009 ; 55( 6 suppl.): A223 res. E-41.[citado 2024 nov. 01 ]
Artigo de periodico
Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays (2009)
Lima Neto, Lidio Gonçalves; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati; Silbiger, Vivian Nogueira; Pastorelli, Carla Prisinzano; Sampaio, Marcelo Ferraz; Armaganijan, Dikran; Rezende, Adriana Augusto de; Doi, Sonia de Quateli; Hirata, Mario Hiroyuki
Source: Genetic Testing and Molecular Biomarkers. Unidade: FCF
Subjects: POLIMORFISMO, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA NETO, Lidio Gonçalves et al. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, v. 13, n. 3, p. 343-347, 2009Tradução . . Disponível em: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147. Acesso em: 01 nov. 2024.
APA
Lima Neto, L. G., Hirata, R. D. C., Luchessi, A. D., Silbiger, V. N., Pastorelli, C. P., Sampaio, M. F., et al. (2009). Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, 13( 3), 343-347. Recuperado de http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
NLM
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 nov. 01 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
Vancouver
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 nov. 01 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
Trabalho de evento-resumo
Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus (2009)
Hirata, Mario Hiroyuki ; Himelfarb, Silvia Tchernin; Marques, Milano Felipe dos Santos Ferreira; Silva, F. A.; Rodrigues, Alice Cristina ; Sampaio, M. P.; Dinkhuysen, J. F.; Bertolami, Marcelo Chiara; Armaganijan, Dikran; Silva, Valéria Ferreira da; Rezende, Adriana Augusto de; Monaco, Maria Isabel del; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry. Conference titles: Annual Meeting of the American Association for Clinical Chemistry. Unidade: FCF
Subjects: DIABETES MELLITUS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. 2009, Anais.. Chicago: American Association for Clinical Chemistry, 2009. p. A223 res. E-41. . Acesso em: 01 nov. 2024.
APA
Hirata, M. H., Himelfarb, S. T., Marques, M. F. dos S. F., Silva, F. A., Rodrigues, A. C., Sampaio, M. P., et al. (2009). Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. In Clinical Chemistry (Vol. 55, p. A223 res. E-41). Chicago: American Association for Clinical Chemistry.
NLM
Hirata MH, Himelfarb ST, Marques MF dos SF, Silva FA, Rodrigues AC, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Monaco MI del, Hirata RDC. Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. Clinical Chemistry. 2009 ;55( 6): A223 res. E-41.[citado 2024 nov. 01 ]
Vancouver
Hirata MH, Himelfarb ST, Marques MF dos SF, Silva FA, Rodrigues AC, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Monaco MI del, Hirata RDC. Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus. Clinical Chemistry. 2009 ;55( 6): A223 res. E-41.[citado 2024 nov. 01 ]
Trabalho de evento-resumo periodico
Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus (2008)
Hirata, Mario Hiroyuki ; Himelfarb, Silvia Tchernin; Marques, Milano Felipe dos Santos Ferreira; Monaco, Maria Isabel del; Rodrigues, Alice Cristina ; Sampaio, Marcelo Ferraz; Dinkhuysen, J. F.; Bertolami, Marcelo Chiara; Armaganijan, Dikran; Silva, Valéria Ferreira da; Rezende, Adriana Augusto de; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry. Conference titles: AACC Annual Meeting. Unidade: FCF
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, DOENÇAS METABÓLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki et al. Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2008
APA
Hirata, M. H., Himelfarb, S. T., Marques, M. F. dos S. F., Monaco, M. I. del, Rodrigues, A. C., Sampaio, M. F., et al. (2008). Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Hirata MH, Himelfarb ST, Marques MF dos SF, Monaco MI del, Rodrigues AC, Sampaio MF, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Hirata RDC. Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. 2008 ;54( 6): A165 res.D-67.[citado 2024 nov. 01 ]
Vancouver
Hirata MH, Himelfarb ST, Marques MF dos SF, Monaco MI del, Rodrigues AC, Sampaio MF, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rezende AA de, Hirata RDC. Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus. Clinical Chemistry. 2008 ;54( 6): A165 res.D-67.[citado 2024 nov. 01 ]
Trabalho de evento-resumo periodico
CD 14, TLR 2;TLR 4 AND IL-6 gene polymorphisms may be associated with acute myocardial infarction in young adult patients (2008)
Lima Neto, Lidio Gonçalves; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati; Silbiger, Vivian Nogueira; Doi, Sonia de Quateli; Rezende, Adriana Augusto de; Armanijan, Dikran; Sampaio, Marcelo Ferraz; Stephano, Marco Antônio ; Hirata, Mario Hiroyuki
Source: Clinical Chemistry. Conference titles: AACC Annual Meeting. Unidade: FCF
Subjects: ARTERIOSCLEROSE, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA NETO, Lidio Gonçalves et al. CD 14, TLR 2;TLR 4 AND IL-6 gene polymorphisms may be associated with acute myocardial infarction in young adult patients. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2008
APA
Lima Neto, L. G., Hirata, R. D. C., Luchessi, A. D., Silbiger, V. N., Doi, S. de Q., Rezende, A. A. de, et al. (2008). CD 14, TLR 2;TLR 4 AND IL-6 gene polymorphisms may be associated with acute myocardial infarction in young adult patients. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Doi S de Q, Rezende AA de, Armanijan D, Sampaio MF, Stephano MA, Hirata MH. CD 14, TLR 2;TLR 4 AND IL-6 gene polymorphisms may be associated with acute myocardial infarction in young adult patients. Clinical Chemistry. 2008 ;54( 6): A166 res.D-71.[citado 2024 nov. 01 ]
Vancouver
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Doi S de Q, Rezende AA de, Armanijan D, Sampaio MF, Stephano MA, Hirata MH. CD 14, TLR 2;TLR 4 AND IL-6 gene polymorphisms may be associated with acute myocardial infarction in young adult patients. Clinical Chemistry. 2008 ;54( 6): A166 res.D-71.[citado 2024 nov. 01 ]
Trabalho de evento-resumo periodico
Estudo da expressão gênica do RANK e RANKL em indivíduos diabéticos tipo 2 em tratamento com pioglitazona (2007)
Himelfarb, Silvia Tchernin; Marques, Milano Felipe dos Santos Ferreira; Silva, Valéria Ferreira da; Monaco, Maria Isabel del; Sampaio, Marcelo Ferraz; Armaganijan, Dikran; Rezende, Adriana Augusto de; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Revista Brasileira de Ciências Farmacêuticas. Conference titles: Congresso Paulista de Farmacêuticos. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIMELFARB, Silvia Tchernin et al. Estudo da expressão gênica do RANK e RANKL em indivíduos diabéticos tipo 2 em tratamento com pioglitazona. Revista Brasileira de Ciências Farmacêuticas. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2007
APA
Himelfarb, S. T., Marques, M. F. dos S. F., Silva, V. F. da, Monaco, M. I. del, Sampaio, M. F., Armaganijan, D., et al. (2007). Estudo da expressão gênica do RANK e RANKL em indivíduos diabéticos tipo 2 em tratamento com pioglitazona. Revista Brasileira de Ciências Farmacêuticas. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Himelfarb ST, Marques MF dos SF, Silva VF da, Monaco MI del, Sampaio MF, Armaganijan D, Rezende AA de, Hirata RDC, Hirata MH. Estudo da expressão gênica do RANK e RANKL em indivíduos diabéticos tipo 2 em tratamento com pioglitazona. Revista Brasileira de Ciências Farmacêuticas. 2007 ;43 62 res.119.[citado 2024 nov. 01 ]
Vancouver
Himelfarb ST, Marques MF dos SF, Silva VF da, Monaco MI del, Sampaio MF, Armaganijan D, Rezende AA de, Hirata RDC, Hirata MH. Estudo da expressão gênica do RANK e RANKL em indivíduos diabéticos tipo 2 em tratamento com pioglitazona. Revista Brasileira de Ciências Farmacêuticas. 2007 ;43 62 res.119.[citado 2024 nov. 01 ]

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em